1. Home
  2. SGHT vs SUPX Comparison

SGHT vs SUPX Comparison

Compare SGHT & SUPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • SUPX
  • Stock Information
  • Founded
  • SGHT 2011
  • SUPX 2021
  • Country
  • SGHT United States
  • SUPX Singapore
  • Employees
  • SGHT N/A
  • SUPX N/A
  • Industry
  • SGHT Medical Specialities
  • SUPX
  • Sector
  • SGHT Health Care
  • SUPX
  • Exchange
  • SGHT Nasdaq
  • SUPX Nasdaq
  • Market Cap
  • SGHT 179.7M
  • SUPX 198.5M
  • IPO Year
  • SGHT 2021
  • SUPX 2024
  • Fundamental
  • Price
  • SGHT $3.69
  • SUPX $49.51
  • Analyst Decision
  • SGHT Buy
  • SUPX
  • Analyst Count
  • SGHT 8
  • SUPX 0
  • Target Price
  • SGHT $4.29
  • SUPX N/A
  • AVG Volume (30 Days)
  • SGHT 125.0K
  • SUPX 268.4K
  • Earning Date
  • SGHT 11-06-2025
  • SUPX 10-24-2025
  • Dividend Yield
  • SGHT N/A
  • SUPX N/A
  • EPS Growth
  • SGHT N/A
  • SUPX N/A
  • EPS
  • SGHT N/A
  • SUPX N/A
  • Revenue
  • SGHT $76,303,000.00
  • SUPX $1,978,875.00
  • Revenue This Year
  • SGHT N/A
  • SUPX N/A
  • Revenue Next Year
  • SGHT $11.32
  • SUPX N/A
  • P/E Ratio
  • SGHT N/A
  • SUPX N/A
  • Revenue Growth
  • SGHT N/A
  • SUPX N/A
  • 52 Week Low
  • SGHT $2.03
  • SUPX $2.75
  • 52 Week High
  • SGHT $7.03
  • SUPX $72.00
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 39.74
  • SUPX 57.08
  • Support Level
  • SGHT $4.09
  • SUPX $46.10
  • Resistance Level
  • SGHT $4.25
  • SUPX $68.24
  • Average True Range (ATR)
  • SGHT 0.16
  • SUPX 10.46
  • MACD
  • SGHT -0.07
  • SUPX 0.80
  • Stochastic Oscillator
  • SGHT 9.16
  • SUPX 49.34

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About SUPX Super X AI Technology Limited Ordinary Shares

Super X AI Technology Ltd is a company that specializes in providing high-quality residential and commercial interior design solutions. Through its subsidiaries, SuperX aims to become a technology company dedicated to developing and delivering next-generation digital infrastructure solutions. It is committed to integrating smart technology into every aspect of its offerings, setting new standards for innovation and excellence in the industry.

Share on Social Networks: